
Company valuation, historical trends, and peer comparisons.
According to Vicapsys Life Sciences, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 16.81M. This represents a change of -71.16% compared to the average of 58.27M of the last 4 quarters.
The mean historical Enterprise Value of Vicapsys Life Sciences, Inc. over the last ten years is 18.21M. The current 16.81M Enterprise Value has changed -7.71% with respect to the historical average. Over the past ten years (40 quarters), VICP's Enterprise Value was at its highest in in the March 2025 quarter at 63.18M. The Enterprise Value was at its lowest in in the March 2009 quarter at 0.
Average
18.21M
Median
7.09M
Minimum
4.01M
Maximum
60.64M
Discovering the peaks and valleys of Vicapsys Life Sciences, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 214.67%
Maximum Annual Enterprise Value = 60.64M
Minimum Annual Increase = -37.49%
Minimum Annual Enterprise Value = 4.01M
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 53.68M | -11.48% |
| 2024 | 60.64M | 152.56% |
| 2023 | 24.01M | 214.67% |
| 2022 | 7.63M | -11.39% |
| 2021 | 8.61M | 31.37% |
| 2020 | 6.55M | 63.38% |
| 2019 | 4.01M | -37.49% |
| 2018 | 6.42M | 31.31% |
| 2017 | 4.89M | -13.68% |
| 2009 | 5.66M | 3.95% |
The current Enterprise Value of Vicapsys Life Sciences, Inc. (VICP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
46.11M
5-year avg
30.91M
10-year avg
18.21M
Vicapsys Life Sciences, Inc.’s Enterprise Value is less than Sanara MedTech Inc. (327.77M), less than MediWound Ltd. (179.48M), less than Turn Therapeutics Inc. (288.88M), greater than Sonoma Pharmaceuticals, Inc. (668.27K), less than Elutia Inc (27.26M), less than MiMedx Group, Inc. (357.84M), greater than BioStem Technologies, Inc. (15.92M), less than Regentis Biomaterials Ltd. (0), greater than CollPlant Biotechnologies Ltd. (7.42M), less than Humacyte, Inc. (96.87M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 327.77M | $294.66M | |
| 179.48M | $174.29M | |
| 288.88M | $293.05M | |
| 668.27K | $5.27M | |
| 27.26M | $36.36M | |
| 357.84M | $478.64M | |
| 15.92M | $21.66M | |
| 0 | $9.62M | |
| 7.42M | $7.71M | |
| 96.87M | $110.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vicapsys Life Sciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Vicapsys Life Sciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Vicapsys Life Sciences, Inc.'s Enterprise Value?
What is the highest Enterprise Value for Vicapsys Life Sciences, Inc. (VICP)?
What is the 3-year average Enterprise Value for Vicapsys Life Sciences, Inc. (VICP)?
What is the 5-year average Enterprise Value for Vicapsys Life Sciences, Inc. (VICP)?
How does the current Enterprise Value for Vicapsys Life Sciences, Inc. (VICP) compare to its historical average?